Apomorphine and ropinirole each keep a place in canine emesis
CURRENT BRIEF VERSION: A recent VetGirl podcast put a practical clinical question back in focus: when a dog needs emesis induction, how should veterinarians think about apomorphine versus ropinirole? The comparison matters because ropinirole ophthalmic solution, marketed as Clevor, remains the only FDA-approved emetic for dogs in the U.S., while apomorphine is still widely used extra-label in practice. The podcast highlighted a 2025 prospective randomized clinical trial conducted at 2 specialty referral hospitals from October 2021 through March 2023 that enrolled 132 client-owned dogs after suspected or confirmed toxin or foreign-body ingestion. Dogs were randomized to ropinirole eye drops (63 dogs) or IV apomorphine (69 dogs), with a second identical dose allowed if vomiting did not occur within 20 minutes. Newer published data suggest the 2 drugs can achieve similar overall emetic success, but with meaningful tradeoffs in onset, route, and adverse effects. In a 2025 crossover study in healthy dogs, ophthalmic ropinirole was reported to be as effective as IV apomorphine overall, although apomorphine produced vomiting faster. A separate emergency-setting study in client-owned dogs with suspected foreign material ingestion also found comparable efficacy, with median time to first emesis of 8.6 minutes for ropinirole versus 1.6 minutes for apomorphine. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary teams, the choice is less about which drug “works” and more about workflow, patient selection, and safety. Ropinirole offers an on-label ophthalmic option for dogs at least 4.5 months old and 1.8 kg, and in the Reeves et al. trial dogs with ocular disease, CNS disease, hepatic disease, prior antiemetic treatment, or ingestion of caustic or volatile substances were excluded, underscoring that emesis decisions still depend heavily on case selection. Its effects can be reversed with a dopamine antagonist such as metoclopramide if vomiting persists. Apomorphine remains familiar and fast, but it is not licensed for emesis induction in U.S. dogs and carries broader dopamine, serotonergic, and opioid receptor activity, which may contribute to sedation and cardiopulmonary effects. Guidance from Illinois notes apomorphine also presents hazardous-drug handling concerns, while ropinirole’s adverse effects more often include transient ocular irritation, third eyelid protrusion, and conjunctival changes. (vetmed.illinois.edu)
What to watch: Expect more discussion around protocol standardization, especially which patients benefit most from ropinirole’s on-label convenience versus apomorphine’s faster onset in emergency decontamination cases. The VetGirl review also reinforces the practical details likely to shape protocols: common ingestion categories in the clinical trial included toxic foods, plants, medications, rodenticides and other poisons, and a wide range of foreign materials and fabrics, with dogs monitored for 40 minutes and rescue antiemetics used when needed. (todaysveterinarypractice.com)